Microbiome Market Trends Supporting 15% CAGR Growth Through 2030
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Microbiome Market Poised To Hit $1.64 Billion By 2030 With A 15% CAGR
The microbiome market has experienced rapid growth in recent years. It is projected to expand from $0.82 billion in 2025 to $0.94 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.8%. This historical growth can be ascribed to factors such as increasing awareness about gut health, greater research funding for microbiome studies, a rise in probiotic consumption, advancements in sequencing technologies, and alliances between research institutions and biotech firms.
The microbiome market is projected to experience swift expansion in the coming years. This market is anticipated to reach a valuation of $1.64 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 15.0%. Several factors will drive this growth during the forecast period, including the incorporation of AI into microbiome analysis, the increasing embrace of personalized medicine, the broadening scope of microbiome-based therapeutics, the growing prevalence of chronic diseases, and the escalating need for functional foods and supplements. Key trends expected during this period encompass tailored microbiome therapies, advancements in probiotics and prebiotics, the evolution of microbiome diagnostics, an increase in gut-brain axis research, and enhanced microbiome data integration and analysis.
Get A Free Sample Report With In-Depth Market Insights:
Microbiome Market Industry Drivers: What’s Behind The Revenue Growth?
Increased healthcare spending is projected to drive the expansion of the microbiome market in the future. This expenditure represents the total financial outlay on , goods, and associated activities within a particular health system or economy over a set timeframe. Such spending is crucial for accelerating the microbiome market, as rising investments in microbiome research and development, coupled with greater understanding of its importance to human health, fuel demand for related therapies and products. For example, the Centers for Medicare & Medicaid Services, a US-based agency overseeing Medicare and Medicaid, reported in December 2024 that U.S. health care expenditures rose by 7.5% in 2023, reaching $4.9 trillion, equating to approximately $14,570 per person. Consequently, escalating healthcare costs are propelling the expansion of the complicated skin and skin structure infections drugs market.
Microbiome Market Segment Trends And Revenue Contributors
The microbiome market covered in this report is segmented –
1) By Microbe Category: Bacteria, Archaea, Viruses, Other Microbiomes
2) By Product: Therapeutics, Diagnostics
3) By Technology: Genomics, Proteomics, Metabolomics
4) By End-Use: Infectious Diseases, Gastrointestinal Disorders, Metabolic Disorders, Cancers, Other Diseases
Subsegments:
1) By Bacteria: Probiotic Bacteria, Pathogenic Bacteria, Environmental Bacteria, Bacterial Communities In Various Ecosystems
2) By Archaea: Methanogens, Halophiles, Acidophiles, Other Extremophiles
3) By Viruses: Bacteriophages, Eukaryotic Viruses, Environmental Viruses
4) By Other Microbiomes: Fungi, Protists, Helminths, Mycobiome
#Microbiome Market Growth Trends: What’s Shaping The Future Outlook?
Major companies in the microbiome market are concentrating on developing innovations such as personalized health insights, which aim to empower individuals by providing customized reports that highlight specific health concerns. Personalized health insights are defined as tailored, data-driven information and recommendations customized to an individual’s unique health profile. For example, in September 2024, Redcliffe Labs, an India-based medical and diagnostic laboratory company, launched its Gut Microbiome and HealthEx tests to enhance preventive healthcare through personalized health insights. These two specialized health tests are focused on promoting preventive healthcare. The gut microbiome test analyzes gut health, offering insights into immune function, metabolism, and mental health, while an advanced blood test evaluates DNA to assess potential health risks related to lifestyle, diet, and genetics. Both tests provide personalized recommendations to help individuals manage their well-being.
Microbiome Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the microbiome market are Seres Therapeutics, Enterome Bioscience, Ferring Pharmaceuticals, Vedanta BioSciences, Second Genome Inc., Microbiotica, Rebiotix Inc, Locus Biosciences, Osel Inc., Xbiome Co. Ltd, Microba Life Sciences, Biome Australia, Shoreline Biome, BugSpeaks, Atlas Biomed, BiomX Ltd, ImmuneBiotech Medical Sweden AB, MetaboGen AB, Viome, PharmaBiome, NCCR Microbiomes, MaaT Pharma, Eligo Bioscience, T3 Pharmaceuticals, MicroBiome Therapeutics LLC, OpenBiome, Microbiome Insights Inc., Lallemand Health Solutions, Mybiotics Pharma, DayTwo, Next Biosciences, ViThera Pharmaceuticals Inc., Inqaba Biotechnical Industries (Pty), SNIPR Biome, MyBiome
View The Full Microbiome Market Report:
Microbiome Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the microbiome market in 2025. The regions covered in the microbiome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
